JPH1072419A - Production of tertiary-leucine - Google Patents

Production of tertiary-leucine

Info

Publication number
JPH1072419A
JPH1072419A JP32701996A JP32701996A JPH1072419A JP H1072419 A JPH1072419 A JP H1072419A JP 32701996 A JP32701996 A JP 32701996A JP 32701996 A JP32701996 A JP 32701996A JP H1072419 A JPH1072419 A JP H1072419A
Authority
JP
Japan
Prior art keywords
reaction
ammonia
leucine
solvent
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP32701996A
Other languages
Japanese (ja)
Inventor
Yuichiro Aratake
裕一郎 荒武
Junko Kudo
順子 工藤
Yasuo Hazama
資雄 間
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP32701996A priority Critical patent/JPH1072419A/en
Publication of JPH1072419A publication Critical patent/JPH1072419A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain the subject compound useful as an intermediate for medicines and agrochemicals in a short time in high yield by reacting a specific carboxylic acid compound with ammonia at a relatively high reaction temperature. SOLUTION: A 2-halo-3,3-dimethylcarboxylic acid compound of the formula (X is a halogen) is reacted with (B) ammonia at 50-200 deg.C. Preferably, the reaction is carried out in a closed system in a solvent such as toluene or under pressure such as equal to or higher than the vapor pressure of the solvent. After the reaction, the reaction mixture is concentrated and the residue is treated by column chromatography.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明はtert−ロイシン
の製造方法に関する。
The present invention relates to a method for producing tert-leucine.

【0002】[0002]

【従来の技術】tert−ロイシンは医農薬の中間体
や、不斉合成触媒の原料などとして有用な化合物であ
る。従来より単工程でtert−ロイシンを製造する方
法として、例えば2−ブロモ−3,3−ジメチル酪酸お
よびアンモニアを37℃で反応させる方法〔Z.Physico
l.Chem.,228,187(1934)、Arch.Biochem.,3,88(1944)〕
が知られているが、この方法は、例えば8日間という長
時間を必要とし、しかも収率が低いという問題があっ
た。
2. Description of the Related Art Tert-leucine is a compound useful as an intermediate for medical and agricultural chemicals, a raw material for asymmetric synthesis catalysts, and the like. As a conventional method for producing tert-leucine in a single step, for example, a method of reacting 2-bromo-3,3-dimethylbutyric acid and ammonia at 37 ° C. [Z. Physico
l. Chem., 228 , 187 (1934), Arch.Biochem., 3 , 88 (1944)]
However, this method requires a long time, for example, 8 days, and has a problem that the yield is low.

【0003】[0003]

【発明が解決しようとする課題】そこで本発明者らは、
短い反応時間で収率よくtert−ロイシンを製造でき
る方法を開発するべく鋭意検討した結果、2−ブロモ−
3,3−ジメチルカルボン酸化合物およびアンモニアを
比較的高い反応温度で反応させることによって、ter
t−ロイシンを短時間で収率よく製造できることを見い
出し、本発明に至った。
SUMMARY OF THE INVENTION Accordingly, the present inventors
As a result of intensive studies to develop a method capable of producing tert-leucine with high yield in a short reaction time, 2-bromo-
By reacting the 3,3-dimethylcarboxylic acid compound and ammonia at a relatively high reaction temperature,
The present inventors have found that t-leucine can be produced in a short time and with good yield, and have reached the present invention.

【0004】[0004]

【課題を解決するための手段】すなわち本発明は、一般
式(1) (式中、Xはハロゲン原子を示す。)で示される2−ハ
ロ−3,3−ジメチルカルボン酸化合物およびアンモニ
アを50〜200℃の温度範囲で反応させることを特徴
とするtert−ロイシンの製造方法を提供するもので
ある。
That is, the present invention provides a compound represented by the following general formula (1): (Wherein X represents a halogen atom). Production of tert-leucine, characterized by reacting a 2-halo-3,3-dimethylcarboxylic acid compound represented by the formula (1) with ammonia in a temperature range of 50 to 200C. It provides a method.

【0005】[0005]

【発明の実施の形態】一般式(1)で示される2−ハロ
−3,3−ジメチルカルボン酸化合物における置換基X
で示されるハロゲン原子としては塩素原子、臭素原子、
ヨウ素原子などが例示され、かかる2−ハロ−3,3−
ジメチルカルボン酸化合物としては2−クロロ−3,3
−ジメチル酪酸、2−ブロモ−3,3−ジメチル酪酸、
2−ヨード−3,3−ジメチル酪酸などが例示される。
BEST MODE FOR CARRYING OUT THE INVENTION The substituent X in a 2-halo-3,3-dimethylcarboxylic acid compound represented by the general formula (1)
As a halogen atom represented by a chlorine atom, a bromine atom,
Examples of the iodine atom and the like include 2-halo-3,3-
As the dimethylcarboxylic acid compound, 2-chloro-3,3
-Dimethylbutyric acid, 2-bromo-3,3-dimethylbutyric acid,
Examples thereof include 2-iodo-3,3-dimethylbutyric acid.

【0006】反応は通常、溶媒中で行われる。かかる溶
媒としては、例えば水や、トルエン、ベンゼン、キシレ
ン、モノクロロベンゼン、n−ヘキサン、シクロヘキサ
ン、ヘプタン、ジエチルエーテル、エチレングリコール
ジエチルエーテルなどの疎水性溶媒、メタノール、エタ
ノール、2−プロパノール、テトラヒドロフラン、アセ
トニトリルなどの親水性溶媒などが挙げられ、これらは
それぞれ単独もしくは2種以上を混合して用いられる。
かかる溶媒の使用量は2−ハロ−3,3−ジメチル酪酸
に対して、通常1〜20重量倍、好ましくは1〜5重量
倍の範囲である。
[0006] The reaction is usually carried out in a solvent. Examples of such a solvent include water, hydrophobic solvents such as toluene, benzene, xylene, monochlorobenzene, n-hexane, cyclohexane, heptane, diethyl ether, and ethylene glycol diethyl ether; methanol, ethanol, 2-propanol, tetrahydrofuran, and acetonitrile. And these are used alone or in combination of two or more.
The amount of the solvent to be used is generally 1 to 20 times, preferably 1 to 5 times the weight of 2-halo-3,3-dimethylbutyric acid.

【0007】反応に際しては、例えば溶媒中で2−ハロ
−3,3−ジメチル酪酸およびアンモニアを混合すれば
よい。アンモニアはアンモニアガスとして供給されても
よいし、溶媒として水を用いる場合はアンモニア水であ
ってもよい。
For the reaction, for example, 2-halo-3,3-dimethylbutyric acid and ammonia may be mixed in a solvent. Ammonia may be supplied as ammonia gas, or may be ammonia water when water is used as the solvent.

【0008】反応におけるアンモニアの使用量は2−ハ
ロ−3,3−ジメチル酪酸に対して通常2モル倍以上、
好ましくは5モル倍以上である。また、反応系は系外に
対して密閉された密閉系であってもよいし、系外に対し
て開放された開放系であってもよいが、反応中に気化し
たアンモニアや反応に用いたアンモニアガスなどが系外
に流出することがない点で、密閉系で反応させることが
好ましい。密閉系で反応させるには、反応系を密閉し得
る反応容器、例えばオートクレーブなどを用いればよ
い。
The amount of ammonia used in the reaction is usually at least 2 times the molar amount of 2-halo-3,3-dimethylbutyric acid.
It is preferably at least 5 mole times. Further, the reaction system may be a closed system that is closed to the outside of the system, or may be an open system that is open to the outside of the system. The reaction is preferably performed in a closed system since ammonia gas and the like do not flow out of the system. In order to carry out the reaction in a closed system, a reaction vessel capable of closing the reaction system, for example, an autoclave may be used.

【0009】反応温度はそれが50℃未満であれば反応
速度が低く収率が劣り、200℃を超えると生成したt
ert−ロイシンが分解する傾向にあるため、50〜2
00℃の範囲である必要があり、好ましくは70〜13
0℃の範囲である。なお溶媒を用いる場合、圧力が低い
と反応温度によっては溶媒が完全に気化することもある
ため、加圧下、例えば該溶媒の蒸気圧以上の圧力の下に
反応させることが好ましい。
When the reaction temperature is lower than 50 ° C., the reaction rate is low and the yield is inferior.
ert-leucine has a tendency to degrade,
It must be in the range of 00 ° C., preferably 70 to 13
It is in the range of 0 ° C. When a solvent is used, if the pressure is low, the solvent may completely evaporate depending on the reaction temperature. Therefore, the reaction is preferably performed under pressure, for example, at a pressure higher than the vapor pressure of the solvent.

【0010】反応は比較的速やかに進行して目的のte
rt−ロイシンが生成し、これは反応後の反応混合物か
ら通常の方法、例えば該反応混合物を濃縮後、残渣をカ
ラムクロマトグラフ処理する方法などによって容易に取
り出すことができる。
The reaction proceeds relatively quickly and the desired te
rt-Leucine is produced and can be easily removed from the reaction mixture after the reaction by a conventional method, for example, a method of concentrating the reaction mixture and then subjecting the residue to column chromatography.

【0011】[0011]

【発明の効果】本発明の方法によれば、短時間で収率よ
くtert−ロイシンを製造することができる。
According to the method of the present invention, tert-leucine can be produced in a short time and with high yield.

【0012】[0012]

【実施例】以下、実施例により本発明をより詳細に説明
するが、本発明はこれら実施例に限定されるものではな
い。
The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples.

【0013】実施例1 2−ブロモ−3,3−ジメチル酪酸6.85g(35m
mol)および28%アンモニア水溶液212.9g
(アンモニア3500mmol)をオートクレーブに入
れて密閉し、100℃に昇温して同温度下で6時間攪拌
した。この時の内部の圧力は5〜8kg/cm2の範囲
であった。その後、反応混合物を減圧濃縮し、残渣を乾
燥して粗結晶8.45gを得た。この粗結晶を高速液体
クロマトグラフ〔展開液:ラウリル硫酸ナトリウムおよ
び硫酸ナトリウムの混合水溶液(ラウリル硫酸ナトリウ
ムの濃度5mmol/リットル、硫酸ナトリウムの濃度
2mmol/リットル)に硫酸を加えてpH2に調整し
た水溶液/アセトニトリル=7/3〕にて分析したとこ
ろ、tert−ロイシンの含有量は3.72gであった
(収率81.6%)。
Example 1 6.85 g (35 m) of 2-bromo-3,3-dimethylbutyric acid
mol) and 212.9 g of a 28% aqueous ammonia solution
(3500 mmol of ammonia) was placed in an autoclave, sealed, heated to 100 ° C., and stirred at the same temperature for 6 hours. The internal pressure at this time was in the range of 5 to 8 kg / cm 2 . Thereafter, the reaction mixture was concentrated under reduced pressure, and the residue was dried to obtain 8.45 g of crude crystals. The crude crystals were subjected to high-performance liquid chromatography [developing solution: aqueous solution prepared by adding sulfuric acid to a mixed aqueous solution of sodium lauryl sulfate and sodium sulfate (concentration of sodium lauryl sulfate 5 mmol / l, concentration of sodium sulfate 2 mmol / l) to pH 2] As a result, the content of tert-leucine was found to be 3.72 g (yield: 81.6%).

【0014】実施例2 28%アンモニア水溶液の使用量を21.3g(アンモ
ニア350mmol)とする以外は実施例1と同様に操
作して、粗結晶(tert−ロイシン含有量3.09
g)を得た(収率67.4%)。
Example 2 A crude crystal (tert-leucine content 3.09) was prepared in the same manner as in Example 1 except that the amount of the 28% aqueous ammonia solution was changed to 21.3 g (350 mmol of ammonia).
g) was obtained (yield: 67.4%).

【0015】実施例3 28%アンモニア水溶液の使用量を42.6g(アンモ
ニア700mmol)とする以外は実施例1と同様に操
作して、粗結晶(tert−ロイシン含有量3.31
g)を得た(収率72.2%)。
Example 3 A crude crystal (tert-leucine content 3.31) was prepared in the same manner as in Example 1 except that the amount of the 28% aqueous ammonia solution was changed to 42.6 g (700 mmol of ammonia).
g) was obtained (yield: 72.2%).

【0016】実施例4 2−ブロモ−3,3−ジメチル酪酸10.54g(54
mmol)をトルエン48gに溶解し、28%アンモニ
ア水溶液212.9g(アンモニア3500mmol)
を加えてオートクレーブに入れて密閉し、次いで100
℃に昇温して同温度下で6時間攪拌した。その後、反応
混合物を減圧濃縮し、残渣を乾燥して粗結晶11.04
gを得た。この粗結晶を実施例1と同様に分析したとこ
ろ、tert−ロイシンの含有量は5.55gであった
(収率78.5%)。
Example 4 10.54 g of 2-bromo-3,3-dimethylbutyric acid (54
mmol) in 48 g of toluene and 212.9 g of a 28% aqueous ammonia solution (3500 mmol of ammonia)
And sealed in an autoclave, then 100
C. and the mixture was stirred at the same temperature for 6 hours. Thereafter, the reaction mixture was concentrated under reduced pressure, and the residue was dried to obtain crude crystals 11.04.
g was obtained. When the crude crystals were analyzed in the same manner as in Example 1, the content of tert-leucine was 5.55 g (yield 78.5%).

【0017】実施例5 2−ブロモ−3,3−ジメチル酪酸6.85g(35m
mol)および「28%アンモニア水溶液212.9g
(アンモニア3500mmol)をオートクレー部に入
れて密閉し、160℃に昇温して同温度下で6時間攪拌
した。その後、反応混合物を減圧濃縮し、残渣を乾燥し
て粗結晶8.01gを得た。この粗結晶を実施例1と同
様にして分析したところ、tert−ロイシンの含有量
は3.23gであった(収率70.4%)。
Example 5 6.85 g (35 m) of 2-bromo-3,3-dimethylbutyric acid
mol) and "212.9 g of 28% aqueous ammonia solution"
(3500 mmol of ammonia) was placed in an autoclave, sealed, heated to 160 ° C., and stirred at the same temperature for 6 hours. Thereafter, the reaction mixture was concentrated under reduced pressure, and the residue was dried to obtain 8.01 g of crude crystals. When the crude crystals were analyzed in the same manner as in Example 1, the content of tert-leucine was 3.23 g (yield: 70.4%).

【0018】実施例6 反応温度を60℃とする以外は実施例5と同様に操作し
て粗結晶を得た。この粗結晶(tert−ロイシンの含
有量:3.67g)を得た(収率80%)。
Example 6 A crude crystal was obtained in the same manner as in Example 5, except that the reaction temperature was changed to 60 ° C. The crude crystals (content of tert-leucine: 3.67 g) were obtained (80% yield).

【0019】比較例1 反応温度を40℃とし、反応時間を2日間とする以外は
実施例5と同様に操作して、粗結晶(tert−ロイシ
ンの含有量:0.83g)を得た(収率18%)。
Comparative Example 1 A crude crystal (content of tert-leucine: 0.83 g) was obtained in the same manner as in Example 5 except that the reaction temperature was 40 ° C. and the reaction time was 2 days. Yield 18%).

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】一般式(1) (式中、Xはハロゲン原子を示す。)で示される2−ハ
ロ−3,3−ジメチルカルボン酸化合物およびアンモニ
アを50〜200℃の温度範囲で反応させることを特徴
とするtert−ロイシンの製造方法。
1. The general formula (1) (Wherein X represents a halogen atom). Production of tert-leucine, characterized by reacting a 2-halo-3,3-dimethylcarboxylic acid compound represented by the formula (1) with ammonia in a temperature range of 50 to 200 ° C. Method.
【請求項2】密閉系で反応させることを特徴とする請求
項1に記載の製造方法。
2. The method according to claim 1, wherein the reaction is carried out in a closed system.
【請求項3】溶媒中で反応させることを特徴とする請求
項1に記載の製造方法。
3. The method according to claim 1, wherein the reaction is carried out in a solvent.
【請求項4】加圧下に反応させることを特徴とする請求
項1に記載の製造方法。
4. The method according to claim 1, wherein the reaction is performed under pressure.
JP32701996A 1996-06-28 1996-12-06 Production of tertiary-leucine Pending JPH1072419A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP32701996A JPH1072419A (en) 1996-06-28 1996-12-06 Production of tertiary-leucine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8-169929 1996-06-28
JP16992996 1996-06-28
JP32701996A JPH1072419A (en) 1996-06-28 1996-12-06 Production of tertiary-leucine

Publications (1)

Publication Number Publication Date
JPH1072419A true JPH1072419A (en) 1998-03-17

Family

ID=26493113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP32701996A Pending JPH1072419A (en) 1996-06-28 1996-12-06 Production of tertiary-leucine

Country Status (1)

Country Link
JP (1) JPH1072419A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009063804A1 (en) 2007-11-16 2009-05-22 Kaneka Corporation Process for production of n-carbamoyl-tert-leucine
WO2010122682A1 (en) 2009-04-24 2010-10-28 株式会社カネカ PROCESS FOR PRODUCTION OF N-ALKOXYCARBONYL-tert-LEUCINES
CN105399642A (en) * 2015-12-29 2016-03-16 南京瓦尔生物医药有限公司 Method for simultaneously preparing D-tert-leucine and L-tert-leucine

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009063804A1 (en) 2007-11-16 2009-05-22 Kaneka Corporation Process for production of n-carbamoyl-tert-leucine
US8183408B2 (en) 2007-11-16 2012-05-22 Kaneka Corporation Process for production of N-carbamoyl-tert-leucine
WO2010122682A1 (en) 2009-04-24 2010-10-28 株式会社カネカ PROCESS FOR PRODUCTION OF N-ALKOXYCARBONYL-tert-LEUCINES
CN105399642A (en) * 2015-12-29 2016-03-16 南京瓦尔生物医药有限公司 Method for simultaneously preparing D-tert-leucine and L-tert-leucine

Similar Documents

Publication Publication Date Title
JPH1072419A (en) Production of tertiary-leucine
JP2000109462A (en) Production of 8-benzylaminoquioline
JP3845977B2 (en) Method for producing 4,4'-bischloromethylbiphenyl
WO1999054281A1 (en) Process for producing dimethylacetamide
JPH0395145A (en) Production of alpha-amino acid
JPH0717935A (en) Production of 3-aminopropionitrile
JPH07330755A (en) Production of piperonal
JP3899626B2 (en) Preparation of 2-mercaptothiazol
KR100407720B1 (en) Preparing Method for N-[3-{3-(1-Piperidinylmethyl)phenoxy}propyl]acetoxyacetamide
JP3959178B2 (en) Method for producing hydrazine derivative, intermediate thereof and method for producing intermediate
JPS6053021B2 (en) Production method of hydantoin
JPH08134038A (en) Production of carbazinic acid
JP3436314B2 (en) Method for producing 2-mercapto-5-methoxybenzimidazole
KR0177618B1 (en) Process for preparation of 2,6-dichloro-5-fluoronicotinic acid
JPS6317869A (en) Production of 2-lower alkyl-4-amino-5-formylpyrimidine
JPS62129242A (en) Production of fluorine-containing alpha,beta-unsaturated carboxylic acid
JP2003128619A (en) Method for producing 3-methyladipic acid
JPS6183164A (en) Preparation of hydrantoin
JPH03204854A (en) Production of 3-amino-1-benzylpyrrolidines
JPH03200751A (en) Production of 2-amino-1-(4-hydroxyphenyl)-ethanone mineral acid salt
JPS60252453A (en) Production of beta-chloroalanine
JPS6335619B2 (en)
JPH09176122A (en) Production of 6-bromonicotinic acid
JPS63201148A (en) Production of 2-phenylisopropylamine
JPS6330480A (en) Production of furfuryl alcohols